2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of …

B Williams, G Mancia, W Spiering… - European heart …, 2018 - academic.oup.com
Aims The expression of GADD153 (growth arrest and DNA damage-inducible gene 153), an
apoptosis-regulated gene, increases during endoplasmic reticulum (ER) stress. How …

Perspectives on improving blood pressure control to reduce the clinical and economic burden of hypertension

G Mancia, FP Cappuccio, M Burnier… - Journal of Internal …, 2023 - Wiley Online Library
The clinical and economic burden of hypertension is high and continues to increase
globally. Uncontrolled hypertension has severe but avoidable long‐term consequences …

2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of …

G Mancia, R Kreutz, M Brunström, M Burnier… - Journal of …, 2023 - journals.lww.com
Document Reviewers: Luis Alcocer (Mexico), Christina Antza (Greece), Mustafa Arici
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …

[PDF][PDF] Guía ESC/ESH 2018 sobre el diagnóstico y tratamiento de la hipertensión arterial

B Williams, G Mancia, W Spiering, E Agabiti Rosei… - Rev Esp …, 2019 - peroxfarma.com
La tarea de elaboración de GPC incluye la creación de herramientas educativas y
programas de implementación de las recomendaciones. Para su implementación, se …

2018 ESC/ESH Guidelines for the Management of Arterial Hypertension: The Task Force for the management of arterial hypertension of the European Society of …

B Williams, G Mancia, W Spiering… - … of Hypertension of …, 2019 - taylorfrancis.com
Guidelines summarize and evaluate available evidence with the aim of assisting health
professionals in selecting the best management strategies for an individual patient with a …

[HTML][HTML] A molecular docking approach to evaluate the pharmacological properties of natural and synthetic treatment candidates for use against hypertension

SA Attique, M Hassan, M Usman, RM Atif… - International journal of …, 2019 - mdpi.com
Cardiovascular diseases (CVDs) have become the leading cause of disability and death
worldwide, particularly in low-and middle-income countries. Hypertension, a major cause of …

Cardiovascular risk reduction after renal denervation according to time in therapeutic systolic blood pressure range

F Mahfoud, G Mancia, RE Schmieder, L Ruilope… - Journal of the American …, 2022 - jacc.org
Background Renal denervation (RDN) has been shown to lower blood pressure (BP), but its
effects on cardiovascular events have only been preliminarily evaluated. Time in therapeutic …

[PDF][PDF] 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of …

M Brunström, M Burnier… - Journal of …, 2023 - docred-strapi-cms-prod.s3.sa-east-1 …
Document Reviewers: Luis Alcocer (Mexico), Christina Antza (Greece), Mustafa Arici
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …

Risk Factor Variability and Cardiovascular Outcome: JACC Review Topic of the Week

FH Messerli, L Hofstetter, SF Rimoldi, E Rexhaj… - Journal of the American …, 2019 - jacc.org
Until recently, intraindividual visit-to-visit variability of cardiovascular risk factors has been
dismissed as random fluctuation. This simplistic concept was challenged by demonstrating …

The impact of systolic and diastolic blood pressure variability on mortality is age dependent: data from the Dublin Outcome Study

G Bilo, E Dolan, E O'Brien, R Facchetti… - European journal of …, 2020 - academic.oup.com
Background Twenty-four-hour blood pressure variability (BPV) is independently related to
cardiovascular outcomes, but limited and conflicting evidence is available on the relative …